Director Buys $707K in Open Market Shares Following Recent Negative Earnings and Restructuring News
XRAY sits 37% above its 52-week low of $9.85.
Summary
A director of Dentsply Sirona purchased over $707,000 in company stock on the open market, signaling confidence after recent negative financial reports and restructuring announcements.
Key Events · Ownership and Investor Activity · XRAY
-
Director Makes Significant Open Market Purchase
Director Gregory T. Lucier acquired 50,000 shares of Dentsply Sirona common stock through two open market purchases on March 2nd and 3rd, 2026, totaling $707,379.44.
-
Strong Vote of Confidence Post-Earnings
This substantial insider buying follows closely on the heels of the company's recent 8-K and 10-K filings (February 26, 2026) which disclosed a significant net loss, a major restructuring, and the elimination of quarterly dividends. The purchase suggests strong insider belief in the company's recovery and future value.
Analysis · XRAY · Industrial Applications And Services
This Form 4 filing indicates a significant open market purchase by Director Gregory T. Lucier, acquiring over $707,000 worth of common stock. This transaction is particularly notable as it occurs just days after Dentsply Sirona reported a substantial net loss for fiscal year 2025, announced a major restructuring, and eliminated its quarterly dividend. The director's decision to make a sizable personal investment immediately following such negative corporate news signals strong confidence in the company's future prospects and management's turnaround plan, potentially offsetting some of the recent bearish sentiment.
At the time of this filing, XRAY was trading at $13.48 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.7B. The 52-week trading range was $9.85 to $17.18. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.